Question · Q3 2025
John Franzreb from Sidoti Company inquired about the updated guidance, specifically the dynamic of increased revenue guidance midpoint alongside a lowered EPS midpoint, and sought clarity on 2026 transportation production rates. He also asked for a ranking of end markets by gross or operating margin contribution and later followed up on industrial market sentiment, diagnostic medical business recovery, tariff navigation strategies, and potential impact from supplier fires.
Answer
CEO Kieran O’Sullivan attributed the revenue increase to strong diversified markets and momentum in aerospace and defense, while CFO Ashish Agrawal clarified that the EPS adjustment was primarily due to an unfavorable impact from recent U.S. tax legislation and a mix of earnings. For 2026 transportation, Mr. O’Sullivan noted a mixed market with some light vehicle positivity and commercial vehicle softness, but solid bookings. Mr. Agrawal explained that margins are strong across diversified markets (medical, industrial, aerospace & defense) and vary more by specific product lines (e.g., Piezo, Single Crystal) rather than broad end markets. Mr. O’Sullivan confirmed positive industrial market sentiment, citing sequential and year-over-year improvements and strong distribution sales. He also noted that while diagnostic medical is solid but weaker, therapeutics show strong momentum. Mr. Agrawal detailed tariff mitigation through localized production and customer/supplier collaboration, highlighting USMCA as a key monitoring point. Mr. O’Sullivan confirmed no direct impact from the Ford aluminum supplier fire but is monitoring the situation.